NOVUS THERAPTCS Revenue, Profits - NVUS Annual Income Statement

Add to My Stocks
$4.84 $0.08 (1.63%) NVUS stock closing price Sep 18, 2018 (Closing)

Looking at financial statements, along with the NOVUS THERAPTCS stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue decrease to $- for 2017 impacts the NVUS stock. Investors typically check year over year or quarter over quarter revenue growth. The NOVUS THERAPTCS profit and loss statement for 2017 shows a net profit of $-13.11M. Profits for last year was $-37.95M. Apart from this an investor should also check NOVUS THERAPTCS assets and NOVUS THERAPTCS free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec201720162015201420132012
NOVUS THERAPTCS Revenues or Net Sales
------
Cost Of Goods Sold (COGS)------
NOVUS THERAPTCS Gross Profit
------
Research & Development Expense2.02M25.02M32.63M14.57M12.2M7.37M
Selling General & Admin Expense11.09M13.09M12.62M8.88M3.54M2.27M
Income Before Depreciation Depletion Amortization-13.12M-38.12M-45.26M-23.46M-15.74M-9.64M
Depreciation Depletion Amortization------
Non Operating Income------
Interest Expense------
NOVUS THERAPTCS Pretax Income
-13.11M-37.95M-45.08M-23.29M-15.72M-9.64M
Provision for Income Taxes------
MinorityInterest------
Investment Gains Losses------
Other Income------
Income Before Extraordinaries & Disc Operations-13.11M-37.95M-45.08M-23.29M-15.72M-9.64M
Extraordinary Items & Discontinued Operations------
NOVUS THERAPTCS Profit/ Loss (Net Income)
-13.11M-37.95M-45.08M-23.29M-15.72M-9.64M
Average Shares used to compute Diluted EPS4.68M-2.5M-1.36M-
Average Shares used to compute Basic EPS4.68M-2.5M-1.36M-
Income Before Nonrecurring Items-13.12M--45.09M-23.3M-15.82M-
Income from Nonrecurring Items------
NOVUS THERAPTCS Earnings Per Share Basic Net
-2.30-15.09-18.09-32.40-11.61-
NOVUS THERAPTCS Earnings Per Share Diluted Net
-2.30--18.09-32.40-11.61-
EPS Diluted Before Nonrecurring Items-2.30--18.09-32.40-11.61-
Preferred Dividends Acc Pd------
Dividends Common------
Dividend Per Share Common0.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

It is very helpful to read a report on NOVUS THERAPTCS stock analysis. An investor must check the following items in an income statement:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $- for this year of 2017. Our NOVUS THERAPTCS revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. NVUS stock had a healthy bottom line growth.

The income statement is also called the profit and loss statement. Apart from the NVUS income statement, one can check the NOVUS THERAPTCS historical stock prices to check how the price has moved with time.

NOVUS THERAPTCS Income Statement - Key Financial Ratios